Author Correction: Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy

• Toshihiro Shibutani,
• Risa Goto,
• Isao Miyazaki,
• Akihiro Hashimoto,
• Takamasa Suzuki,
• Keiji Ishida,
• Tomonori Haruma,
• Toshihiro Osada,
• Takafumi Harada,
• Hidenori Fujita,
• Shuichi Ohkubo

Affiliations

Toshihiro Shibutani

Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.

Risa Goto

Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.

Isao Miyazaki

Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.

Akihiro Hashimoto

Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.

Takamasa Suzuki

Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.

Keiji Ishida

Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.

Tomonori Haruma

Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.

Toshihiro Osada

Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.

Takafumi Harada

Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.

Hidenori Fujita

Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.

Shuichi Ohkubo

Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.